
|
Use our drug profile search engine to review information about current FDA appproved cancer drugs. A chemotherapy drug or supportive care agent may be referred to by different names. Typically, when a drug is first approved by the FDA for clinical use, the tradename selected by the manufacturer is used. However, the same agent may also be referred to by its chemical name. Once the original manufacturers patent on the drug has expired, other manufacturers, with FDA approval, are allowed to produce and market the same chemical compound which is typically referred to as a "generic" form of the original. Sometimes these manufacturers will market the generic form under a new tradename to help identify it in the marketplace. Finally, the actual chemical name of the compound is sometimes used by medical professionals rather than the tradename or generic name. Our drug dictionary is organized by alphabet, including both generic and trade names. Alternately, you may view a list of drugs by "class."
Class: Hormonal therapy Generic Name: Anastrozole (ah-NAS-tre-zole) For which conditions is this drug approved? Anastrozole is FDA approved for the treatment of postmenopausal women with hormone-positive breast cancer. It is important for patients to remember that physicians have the ability to prescribe medication for conditions other than those for which the drug has been approved by the FDA. Patients who have received a prescription of this drug for a condition other than which it is approved may wish to discuss this issue with their physician.
How is anastrozole typically given (administered)? Anastrozole is administered as a pill once daily. It is eliminated in the body through the urine and feces. How are patients typically monitored? Patients will usually have scheduled meetings with their healthcare provider while they are being treated with anastrozole. Typically, blood will be drawn to check levels of blood cells and to monitor functions of some organ systems, such as the kidneys or liver. Patients may also undergo physical examinations, scans or other measures to assess side effects and response to therapy. If a physician feels that a patient is at risk for osteoporosis (reduction in bone density), scans to determine bone density may be ordered prior to or during treatment with anastrozole, as the risk of bone fractures may be increased during treatment.
What are the common (occur in 30% or more of patients) side effects of treatment with anastrozole? What are the less common (occur in 10% to 29% of patients) side effects of treatment with anastrozole? This is not a complete list of side effects. Some patients may experience other side effects that are not listed here. Patients may wish to discuss with their physician the other less common side effects of this drug, some of which may be serious. Some side effects may require medical attention. Other side effects do not require medical attention and may go away during treatment. Patients should check with their physician about any side effects that continue or are bothersome. What can patients do to help alleviate or prevent discomfort and side effects? • Pay careful attention to the physician’s instructions and inform the physician of any side effects.
• If an oral dose is missed, do not double up on doses. Patients should contact their physician in this event. When should patients notify their physician? • Prolonged or severe nausea or vomiting What is a package insert? Copyright © 2005 Cancer Consultants Last updated 01/05. Important Limitations of Use As with any printed reference, the use of particular drugs, regimes and drug dosages may become out-of-date over time, since new information may have been published and become generally accepted after the latest update to this printed information. Please keep in mind that health care professionals are fully responsible for practicing within current standards, avoiding use of outdated regimens, employing good clinical judgment in selecting drugs and/or regimens, in calculating doses for individual patients, and verifying all dosage calculations. DISCLAIMER OF WARRANTIES CANCERCONSULTANTS.COM SPECIFICALLY DISCLAIMS AND EXCLUDES ALL EXPRESSED OR IMPLIED WARRANTIES, INCLUDING ANY IMPLIED WARRANTIES AS TO QUALITY, ACCURACY (INCLUDING TYPOGRAPHICAL ERRORS), MERCHANTABILITY, OR FITNESS FOR ANY PARTICULAR PURPOSE OF THE INFORMATION CONTAINED HEREIN. CANCERCONSULTANTS.COM DISCLAIMS ALL LIABILITY OR DAMAGES ARISING FROM ANY USE OF THE INFORMATION. The prescribing physician is solely responsible for making all decisions relating to appropriate patient care including, but not limited to, drugs, regimens, dose, schedule, and any supportive care.
|